Liaoning Cancer Hospital and Institute
Liaoning Cancer Hospital and Institute
Shenyang, Liaoning, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer | Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer | Recruiting | Phase 2 | 2026-07-27 | NCT07122687 | |
| Pseudomonas Aeruginosa Injection Combined With Polyvinylpyrrolidone-Iodine in Immediate Breast Reconstruction Surgery With Implants | Postoperative Seroma Rate, Drainage Tube Removal Time, and Capsular Contracture Rate; Seroma Following Procedure | Enrolling by invitation | Not applicable | 2026-03-10 | NCT07460297 | |
| A Phase 2 Clinical Study of ABSK061 and ABSK043 | Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, transitional cell carcinoma, urothelial carcinoma | Recruiting | Phase 2 | 2024-11-19 | NCT06632262 |